ASSET | DATE | % RETURN |
---|---|---|
Vigil Neuroscience (VIGL) | 7/1/2022 - 9/30/2022 | 262.55% |
AMTD Digital (HKD) | 7/1/2022 - 9/30/2022 | 260% |
Vertical Aerospace (EVTL) | 7/1/2022 - 9/30/2022 | 192.5% |
NRx Pharmaceuticals (NRXPW) | 7/1/2022 - 9/30/2022 | 184.36% |
Verve Therapeutics (VERV) | 7/1/2022 - 9/30/2022 | 124.36% |
Target Hospitality (TH) | 7/1/2022 - 9/30/2022 | 120.63% |
Ardelyx (ARDX) | 7/1/2022 - 9/30/2022 | 105.17% |
Avadel Pharmaceuticals (AVDL) | 7/1/2022 - 9/30/2022 | 104.49% |
Enovix (ENVX) | 7/1/2022 - 9/30/2022 | 104.18% |
Enliven Therapeutics (ELVN) | 7/1/2022 - 9/30/2022 | 91.6% |
Dyne Therapeutics (DYN) | 7/1/2022 - 9/30/2022 | 84.59% |
89bio (ETNB) | 7/1/2022 - 9/30/2022 | 81.5% |
Sigma Lithium Resources (SGML) | 7/1/2022 - 9/30/2022 | 79.24% |
Viridian Therapeutics (VRDN) | 7/1/2022 - 9/30/2022 | 76.81% |
Applied Opt (AAOI) | 7/1/2022 - 9/30/2022 | 75.48% |
Capricor Therapeutics (CAPR) | 7/1/2022 - 9/30/2022 | 73.91% |
Cogent Biosciences (COGT) | 7/1/2022 - 9/30/2022 | 70.51% |
Tsakos Energy Navigation (TEN) | 7/1/2022 - 9/30/2022 | 69.89% |
Clearfield (CLFD) | 7/1/2022 - 9/30/2022 | 69.35% |
Xometry (XMTR) | 7/1/2022 - 9/30/2022 | 67.77% |
Weave Communications (WEAV) | 7/1/2022 - 9/30/2022 | 66.67% |
International Seaways (INSW) | 7/1/2022 - 9/30/2022 | 66.56% |
BioLife Solutions (BLFS) | 7/1/2022 - 9/30/2022 | 66.42% |
Harrow Health (HROW) | 7/1/2022 - 9/30/2022 | 64.89% |
Fulcrum Therapeutics (FULC) | 7/1/2022 - 9/30/2022 | 64.43% |